重复静脉注射钆布醇不会导致未增强T1加权图像信号强度增高:基于体素的全脑分析
该回顾性单中心研究纳入217例临床孤立综合征患者,基线及至少一次年度随访均静脉注射0.1 mmol/kg体重的钆布醇,采用DARTEL标准化和基于体素的全脑分析计算灰质、白质及脑脊液信号强度比值。结果显示最多5次钆布醇给药后灰质和白质信号强度无显著变化,灰质-脑脊液及白质-脑脊液比值亦无显著改变。
要点
- 基于体素的全脑分析未显示重复给予钆布醇后灰质和白质信号强度增高。
- 最多5次钆布醇给药后,灰质-脑脊液及白质-脑脊液信号比值无显著变化。
- 钆基对比剂分子结构可能是导致未增强T1WI信号增高的关键因素。
核心结论
- 基于体素的全脑分析未显示重复给予钆布醇后未增强T1加权图像上灰质和白质信号强度增高,钆基对比剂分子结构可能是导致信号增高的关键因素。
研究设计与样本
- 回顾性单中心研究纳入217例临床孤立综合征患者,基线及至少一次年度随访脑MRI均静脉注射0.1 mmol/kg体重钆布醇,采用DARTEL标准化计算灰质、白质和脑脊液组织模板及灰质-脑脊液、白质-脑脊液比值,基于体素的全脑分析计算每个体素信号强度,配对t检验比较与基线的差异。
关键影像表现/征象
- 基于体素的全脑分析显示最多5次钆布醇给药后灰质和白质信号强度无显著变化。
- 灰质-脑脊液比值及白质-脑脊液比值均无显著变化。
诊断标准与关键数值
- 采用DARTEL标准化流程计算灰质、白质和脑脊液组织模板及灰质-脑脊液、白质-脑脊液比值。
- 基于体素的全脑分析计算每个数据集每个体素的信号强度,配对t检验比较与基线MRI的差异。
- 每次静脉注射钆布醇剂量为0.1 mmol/kg体重。
临床应用与阅片要点
- 原文结论提示钆布醇在已验证剂量下重复给药未导致未增强T1WI信号强度增高。
- 基于体素的全脑分析可用于评估信号强度的细微变化。
- 原文指出钆基对比剂分子结构可能是导致未增强T1WI信号增高的关键因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To identify a possible association between repeated intravenous administration of gadobutrol and increased signal intensity in the grey and white matter using voxel-based whole-brain analysis.
METHODS: In this retrospective single-centre study, 217 patients with a clinically isolated syndrome underwent baseline brain magnetic resonance imaging and at least one annual follow-up examination with intravenous administration of 0.1 mmol/kg body weight of gadobutrol. Using the "Diffeomorphic Anatomical Registration using Exponentiated Lie algebra" (DARTEL) normalisation process, tissue templates for grey matter (GM), white matter (WM), and cerebrospinal fluid (CSF) were calculated, as were GM-CSF and WM-CSF ratios. Voxel-based whole-brain analysis was used to calculate the signal intensity for each voxel in each data set. Paired t-test was applied to test differences to baseline MRI for significance.
RESULTS: Voxel-based whole-brain analysis demonstrated no significant changes in signal intensity of grey and white matter after up to five gadobutrol administrations. There was no significant change in GM-CSF and grey WM-CSF ratios.
CONCLUSION: Voxel-based whole-brain analysis did not demonstrate increased signal intensity of GM and WM on unenhanced T1-weighted images after repeated gadobutrol administration. The molecular structure of gadolinium-based contrast agent preparations may be an essential factor causing SI increase on unenhanced T1-weighted images.
KEY POINTS: • Repeated administration of gadobutrol does not lead to increased signal intensity. • Voxel-based whole-brain analysis allows assessment of subtle changes in signal intensity. • Macrocyclic contrast agents in a proven dosage are safe.
引用
- Langner S, Kromrey ML, Kuehn JP, et al. Repeated intravenous administration of gadobutrol does not lead to increased signal intensity on unenhanced T1-weighted images-a voxel-based whole brain analysis. Eur Radiol. 2017. PMID: 28289935. doi:10.1007/s00330-017-4777-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。